81_FR_70625 81 FR 70428 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

81 FR 70428 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 197 (October 12, 2016)

Page Range70428-70428
FR Document2016-24520

Federal Register, Volume 81 Issue 197 (Wednesday, October 12, 2016)
[Federal Register Volume 81, Number 197 (Wednesday, October 12, 2016)]
[Notices]
[Page 70428]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-24520]



[[Page 70428]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel, BPN: Small Molecule Drug 
Discovery and Development.
    Date: November 4, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC 
20036.
    Contact Person: Joel Saydoff, Ph.D., Scientific Review Officer, 
Scientific Review Branch, Division of Extramural Research, NINDS/
NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 
9529, Bethesda, MD 20892-9529, 301-496-9223, [email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel, Stroke Clinical Trials.
    Date: November 8, 2016.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Lorien Hotel and Spa, 1600 King Street, Alexandria, VA 
22314.
    Contact Person: Shanta Rajaram, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 
3204, MSC 9529, Bethesda, MD 20892-9529, 301-496-6033, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)


    Dated: October 5, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-24520 Filed 10-11-16; 8:45 am]
 BILLING CODE 4140-01-P



                                                  70428                     Federal Register / Vol. 81, No. 197 / Wednesday, October 12, 2016 / Notices

                                                  DEPARTMENT OF HEALTH AND                                DEPARTMENT OF HEALTH AND                                The meeting will be closed to the
                                                  HUMAN SERVICES                                          HUMAN SERVICES                                        public in accordance with the
                                                                                                                                                                provisions set forth in sections
                                                  National Institutes of Health                           National Institutes of Health                         552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                                                                                as amended. The grant applications and
                                                  National Institute of Neurological                      National Center for Advancing                         the discussions could disclose
                                                  Disorders and Stroke; Notice of Closed                  Translational Sciences; Notice of                     confidential trade secrets or commercial
                                                  Meetings                                                Closed Meeting                                        property such as patentable material,
                                                    Pursuant to section 10(d) of the                        Pursuant to section 10(d) of the                    and personal information concerning
                                                  Federal Advisory Committee Act, as                      Federal Advisory Committee Act, as                    individuals associated with the grant
                                                  amended (5 U.S.C. App.), notice is                      amended (5 U.S.C. App.), notice is                    applications, the disclosure of which
                                                  hereby given of the following meetings.                 hereby given of the following meeting.                would constitute a clearly unwarranted
                                                    The meetings will be closed to the                      The meeting will be closed to the                   invasion of personal privacy.
                                                  public in accordance with the                           public in accordance with the                           Name of Committee: Center for Inherited
                                                  provisions set forth in sections                        provisions set forth in sections                      Disease Research Access Committee.
                                                  552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              Date: November 10, 2016
                                                  as amended. The grant applications and                  as amended. The grant applications and                  Time: 11:30 a.m. to 12:30 p.m.
                                                  the discussions could disclose                          the discussions could disclose                          Agenda: To review and evaluate grant
                                                                                                                                                                applications.
                                                  confidential trade secrets or commercial                confidential trade secrets or commercial                Place: National Institutes of Health, Suite
                                                  property such as patentable material,                   property such as patentable material,                 3049, 5635 Fishers Lane, Bethesda, MD
                                                  and personal information concerning                     and personal information concerning                   20892, (Telephone Conference Call).
                                                  individuals associated with the grant                   individuals associated with the grant                   Contact Person: Barbara J Thomas, Ph.D.,
                                                  applications, the disclosure of which                   applications, the disclosure of which                 Scientific Review Officer, Scientific Review
                                                  would constitute a clearly unwarranted                  would constitute a clearly unwarranted                Branch, National Human Genome Research
                                                  invasion of personal privacy.                           invasion of personal privacy.                         Institute, National Institutes of Health, 5635
                                                                                                                                                                Fishers Lane, Ste. 4076, MSC 9306, Bethesda,
                                                    Name of Committee: National Institute of                Name of Committee: National Center for              MD 20892–9306, 301–402–0838,
                                                  Neurological Disorders and Stroke Special               Advancing Translational Sciences Special              barbara.thomas@nih.gov.
                                                  Emphasis Panel, BPN: Small Molecule Drug                Emphasis; Panel Conference Grants R13.
                                                  Discovery and Development.                                Date: November 2, 2016.                             (Catalogue of Federal Domestic Assistance
                                                    Date: November 4, 2016.                                 Time: 8:00 a.m. to 5:00 p.m.                        Program Nos. 93.172, Human Genome
                                                    Time: 8:00 a.m. to 6:00 p.m.                            Agenda: To review and evaluate grant                Research, National Institutes of Health, HHS)
                                                    Agenda: To review and evaluate grant                  applications.                                           Dated: October 5, 2016.
                                                  applications.                                             Place: National Institutes of Health, One           Sylvia L. Neal,
                                                    Place: St. Gregory Hotel, 2033 M Street,              Democracy Plaza, Room 1066, 6701
                                                                                                          Democracy Boulevard, Bethesda, MD 20892               Program Analyst, Office of Federal Advisory
                                                  NW., Washington, DC 20036.
                                                                                                          (Virtual Meeting).                                    Committee Policy.
                                                    Contact Person: Joel Saydoff, Ph.D.,
                                                  Scientific Review Officer, Scientific Review              Contact Person: Barbara J. Nelson, Ph.D.,           [FR Doc. 2016–24516 Filed 10–11–16; 8:45 am]
                                                  Branch, Division of Extramural Research,                Scientific Review Officer, Office of Scientific       BILLING CODE 4140–01–P
                                                  NINDS/NIH/DHHS, Neuroscience Center,                    Review, National Center for Advancing
                                                  6001 Executive Blvd., Suite 3204, MSC 9529,             Translational Sciences (NCATS), National
                                                  Bethesda, MD 20892–9529, 301–496–9223,                  Institutes of Health, 6701 Democracy Blvd.,           DEPARTMENT OF HEALTH AND
                                                  joel.saydoff@nih.gov.                                   Democracy 1, Room 1080, Bethesda, MD
                                                                                                          20892–4874, 301–435–0806, nelsonbj@
                                                                                                                                                                HUMAN SERVICES
                                                    Name of Committee: National Institute of              mail.nih.gov.
                                                  Neurological Disorders and Stroke Special                                                                     National Institutes of Health
                                                                                                          (Catalogue of Federal Domestic Assistance
                                                  Emphasis Panel, Stroke Clinical Trials.
                                                                                                          Program Nos. 93.859, Pharmacology,                    National Institute on Drug Abuse;
                                                    Date: November 8, 2016.
                                                                                                          Physiology, and Biological Chemistry
                                                    Time: 8:00 a.m. to 8:00 p.m.
                                                                                                          Research; 93.350, B—Cooperative
                                                                                                                                                                Notice of Closed Meeting
                                                    Agenda: To review and evaluate grant
                                                                                                          Agreements; 93.859, Biomedical Research                 Pursuant to section 10(d) of the
                                                  applications.                                           and Research Training, National Institutes of
                                                    Place: Lorien Hotel and Spa, 1600 King                                                                      Federal Advisory Committee Act, as
                                                                                                          Health, HHS)
                                                  Street, Alexandria, VA 22314.                                                                                 amended (5 U.S.C. App), notice is
                                                    Contact Person: Shanta Rajaram, Ph.D.,                  Dated: October 5, 2016.                             hereby given of the following meeting.
                                                  Scientific Review Officer, Scientific Review            David Clary,                                            The meeting will be closed to the
                                                  Branch, Division of Extramural Research,                Program Analyst, Office of Federal Advisory           public in accordance with the
                                                  NINDS/NIH/DHHS, Neuroscience Center,                    Committee Policy.                                     provisions set forth in sections
                                                  6001 Executive Blvd., Suite 3204, MSC 9529,
                                                  Bethesda, MD 20892–9529, 301–496–6033,
                                                                                                          [FR Doc. 2016–24515 Filed 10–11–16; 8:45 am]          552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                  rajarams@mail.nih.gov.                                  BILLING CODE 4140–01–P                                as amended. The contract proposals and
                                                  (Catalogue of Federal Domestic Assistance
                                                                                                                                                                the discussions could disclose
                                                  Program Nos. 93.853, Clinical Research                                                                        confidential trade secrets or commercial
                                                  Related to Neurological Disorders; 93.854,              DEPARTMENT OF HEALTH AND                              property such as patentable material,
                                                  Biological Basis Research in the                        HUMAN SERVICES                                        and personal information concerning
                                                  Neurosciences, National Institutes of Health,                                                                 individuals associated with the contract
                                                  HHS)                                                    National Institutes of Health
mstockstill on DSK3G9T082PROD with NOTICES




                                                                                                                                                                proposals, the disclosure of which
                                                                                                          National Human Genome Research                        would constitute a clearly unwarranted
                                                    Dated: October 5, 2016.                                                                                     invasion of personal privacy.
                                                  Sylvia L. Neal,                                         Institute; Notice of Closed Meeting
                                                                                                                                                                  Name of Committee: National Institute on
                                                  Program Analyst, Office of Federal Advisory               Pursuant to section 10(d) of the                    Drug Abuse Special Emphasis Panel;
                                                  Committee Policy.                                       Federal Advisory Committee Act, as                    Preclinical Medications Discovery and Abuse
                                                  [FR Doc. 2016–24520 Filed 10–11–16; 8:45 am]            amended (5 U.S.C. App.), notice is                    Liability Testing for NIDA (8932).
                                                  BILLING CODE 4140–01–P                                  hereby given of the following meeting.                  Date: November 29, 2016.



                                             VerDate Sep<11>2014   20:13 Oct 11, 2016   Jkt 241001   PO 00000   Frm 00043   Fmt 4703   Sfmt 4703   E:\FR\FM\12OCN1.SGM   12OCN1



Document Created: 2016-10-12 00:55:08
Document Modified: 2016-10-12 00:55:08
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 4, 2016.
FR Citation81 FR 70428 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR